Beranda › Kanker Paru Non-Sel Kecil › California › Concord
Uji klinis Kanker Paru Non-Sel Kecil di Concord, CA
14 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Concord (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi jauhnya
- John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi jauhnya
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Menerima pesertaFase 3
- Local Institution - 0208, Pleasant Hill · 3 mi jauhnya
- BASS Cancer Center, Walnut Creek · 5 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- John Muir Health Clinical Research Center, Concord
- John Muir Health Cancer Center, Walnut Creek · 5 mi jauhnya
- John Muir Health Clinical Research Center, Walnut Creek · 5 mi jauhnya
- dan 1 lainnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 5 mi jauhnya
- John Muir Health Clinical Research Center, Walnut Creek · 5 mi jauhnya
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- BASS Cancer Center, Walnut Creek · 5 mi jauhnya
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Menerima pesertaStudi observasional
- John Muir Health, Walnut Creek · 5 mi jauhnya
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Menerima pesertaFase 2/3
- John Muir Clinical Research Center, Concord
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Research Site, Walnut Creek · 5 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- BASS Cancer Center, Walnut Creek · 5 mi jauhnya
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Walnut Creek · 5 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi jauhnya
- Contra Costa Regional Medical Center, Martinez · 6 mi jauhnya
- Contra Costa Regional Medical Center, Martinez · 6 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Concord
- Obesitas18 studi
- Kelebihan Berat Badan16 studi
- Gangguan Depresi Mayor12 studi
- Diabetes Tipe 210 studi
- Kanker Payudara9 studi
- Kanker Paru9 studi
- Migrain8 studi
- Kanker (semua jenis)7 studi
- Depresi6 studi
- Kanker Prostat6 studi
- Diabetes5 studi
- Penyakit Alzheimer5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.